RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expression
Ian Y. Zhang(Beijing Tongren Hospital), Behnam Badie(City Of Hope National Medical Center), Rongrui Liang(Beckman Research Institute), Kimberley-Jane C. Bonjoc(City Of Hope National Medical Center), Eric F. Medina(University of California, Irvine), Mojtaba Dayyani(City Of Hope National Medical Center), Ammar Chaudhry(City Of Hope National Medical Center), Qingxiao Fang(Harbin Medical University), Lyuzhi Ren(City Of Hope National Medical Center), Jie Zhao(Wuhan University), Leying Zhang(City Of Hope National Medical Center), Aleksandr Filippov(City of Hope), Andrea H. Bild(City Of Hope National Medical Center), Shunan Liu(Jilin University)
Cited by 16
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
|Clinical Cancer Research|2010|180